valu usd unless otherwis note
agn updat via bring littl surpris
view agn releas first quarter morn
come ahead anticip deal close may revenu
consensu larg stale forecast
expect aesthet global botox coolsculpt breast light
gener expect see near-term pressur
ultim revers updat pro-forma model littl
deal set close updat provid visibl
head toward first time pro-forma guidanc million
street million forecast f/
 sever move part varianc exhibit larg
expect aesthet lower rel consensu us facial
plastic surgeri botox therapeut call
call gi women also lower eyecar
specif restasi off-set case prior
quarter await gener saw similar trend around
aesthet even greater varianc perform encourag
includ vraylar realli see much slowdown despit march
disrupt overal impact mind see
meaning surpris number
abbv/agn pro-forma model larg unchang updat
estim exhibit like focu first time
pro-forma guid think like tell whole
pictur beyond partial year core aesthet busi would
becom pro-forma revenu temporarili significantli
impact shut-down expect bounc back
hard like wareh effect patient chase catch-
treatment even past recess busi resili
cash pay attribut provid shelter anticip payor shift
next year drill get
report deep dive bring pro-forma forecast
outlook set-up
stock per note three main question
continu see upsid rais target core
busi deliv ii potenti v-shape recoveri
aesthet busi think like base
seen past downturn iii potenti aggress
quicker synergi captur combin target synergi
oper expens lead time prepar
overal point strength set well
 particularli investor wait deal close
better visibl around busi resili get involv
price prior trade day market close estimate unless otherwis note
capit market appreci consider institut investor all-america research survey
bloomberg capit market estim upside/downside/target
base case see price target impli price-to-earnings
pro-forma ep
assum may deal close allergan
specif addit accret built estim
expect continu annual busi develop
strong uptak key growth product skyrizi
assum slowdown
econom downturn
upsid case scenario see price target impli
price-to-earnings pro-forma ep
invest thesi base view
gener double-digit near-term growth back
 catch-up strength core franchis
continu long-term question post us
humira loss exclus loe see dividend support
synergy-driven support next three year
thesi base follow key point support
see greater impact street around
expect catch-up signific
support robust growth biggest concern around
aesthet franchis would compris
pro-forma revenu follow immunolog slow-down
check suggest bounc back meaning
long-term growth stori still unclear valuat
price littl humira goe biosimilar
see pressur out-year earn time
next year balanc sheet focu
reposit long-term growth also see option
around spin ipo acquir medic aesthet
believ highest dividend lowest
valuat could support share see upsid
potenti offens post recoveri
trade close histor low see cash flow support
current sector-high dividend help support
share anticip recoveri
faster uptak key growth product skyrizi
assum deal close allergan addit
accret built estim
lower humira eros follow us loss exclus
quicker clear relat pandem
potenti catalyst close allergan acquisit may
sever data read focu rinvoq ph data
atop derm skyrizi motiv data
cd induct bi voltaire-x interchang studi
read-out biosimilar humira head-to-head calquence/
imbruvica data r/r cll
risk thesi delay close allergan deal
competit risk particularli around hem-onc franchis
botox slower uptak key grower greater
expect impact
downsid case scenario see price target
impli price-to-earnings downsid pro-forma ep
sluggish uptak key growth product skyrizi
assum prolong deal closur allergan and/or
stringent ftc divestitur requir expect
aggress humira eros follow us loss
exclus expect
greater impact expect
forma incom stand-alon modellegaci stand-alon modelless net product zenpep contributiongross profit cost synergi year oper incom expens foreign exchang incom expens interest expens incom tax tax earn ep share share per rate legaci legaci net profit analysi share per exhibit product varianc us special therapeut
note subtot consensu column may reconcil
note subtot consensu column may reconcil
us special therapeut vs actualstreet vs actualreport estimate varianceconsensusvari aesthet surgeri medicin contour dermatolog urolog us special vs actualstreet vs actualreport estimate varianceconsensusvarianceu gener nervou system gi brand gener exhibit product varianc
note subtot consensu column may reconcil
vs actualstreet vs actualreport aesthet surgeri medicin contour exhibit
 incom guid appr op growth product profit guid approach guid guid salesoper incom guid sale expens guid billionnet foreign exchang incom expens interest expens incom tax tax guid adjust tax rate earn ep guid share share guid flatdividend per increas announc yield price dividend yield assum annual increasesebitda guid approach guid guid salesoper guid sale guid profit analysi guid appr op growth share per inc
price target base equal ev/ebitda price-to-earnings estim reflect
close allergan acquisit use multipl respect
reflect meaning discount histor industri averag adjust us loss
exclus humira impli return price target support outperform
risk rate price target
risk rate price target includ limit tail valu risk
humira still meaning contributor combin compani acquisit risk work
close integr allergan transact largest deal histori
regulatory/polit risk broadli applic sector particularli around pricing/
global biopharmaceut compani base chicago il spun
abbott becam independ publicly-trad compani compani
track record acquisit pharmacycl stemcentrx
announc acquisit allergan expect close upon
close allergan transact combin compani focus immunolog
hematolog oncolog medic aesthet neurosci franchis
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
member compani capit market one affili manag co-manag public offer secur
abbvi inc past month
member compani capit market one affili receiv compens invest bank servic
abbvi inc past month
capit market llc make market secur abbvi inc
member compani capit market one affili receiv compens product servic
invest bank servic abbvi inc past month time member compani capit
market one affili provid non-secur servic abbvi inc
capit market current provid abbvi inc non-secur servic
capit market provid abbvi inc invest bank servic past month
capit market llc make market secur allergan public limit compani
explan capit market equiti rate system
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular stock repres sole analyst view stock perform next month rel
outperform expect materi outperform sector averag month
sector perform sp return expect line sector averag month
under-perform return expect materi sector averag month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate price target estim remov due applic legal regulatori polici constraint
may includ capit market act advisori capac involv compani
march capit market discontinu top pick rate top pick rate secur repres analyst best
idea sector expect provid signific absolut return month favor risk-reward ratio top pick
rate secur reassign outperform rate secur categori secur expect materi
outperform sector averag month
specul risk rate reflect secur lower level financi oper predict illiquid share trade volum
high balanc sheet leverag limit oper histori result higher expect financi and/or stock price volatil
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate outperform
sector perform sp under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
rate price target histori abbvi inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
rate price target histori allergan public limit compani agn us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
refer recommend list recommend histori chart may includ one recommend list model
portfolio maintain wealth manag one affili wealth manag recommend list includ
guid portfolio prime incom rl guid portfolio dividend growth rl guid portfolio adr rl
guid portfolio cap growth rl capit market recommend list includ strategi focu list
fundament equiti weight portfolio abbrevi rl mean date secur place
recommend list abbrevi rl mean date secur remov recommend list
equiti valuat risk
valuat method use determin risk may imped achiev price target cover compani pleas
see recent company-specif research report http //www rbcinsightresearch com send request capit
price target base equal ev/ebitda price-to-earnings estim reflect close allergan
acquisit use multipl respect reflect meaning discount histor industri averag
adjust us loss exclus humira impli return price target support outperform rate
risk rate price target
risk rate price target includ limit tail valu risk humira still meaning contributor
combin compani acquisit risk work close integr allergan transact largest deal
histori regulatory/polit risk broadli applic sector particularli around pricing/reimburs
price target reflect offer cash share current trade price per share
impli ep estim stand-alone estim reflect single-digit ep growth forecast lack
meaning near-term catalyst drive upsid price target impli return support sector perform rate
risk rate price target
risk price target rate includ limit inabl convert pipelin product competit key
product prove intens model activist pressur
capit market polici manag conflict interest relat invest research avail us request
access current polici client refer
send request capit market research publish bay street royal bank plaza floor south
tower toronto ontario reserv right amend supplement polici time
dissemin research short-term trade idea
capit market endeavor make reason effort provid research simultan elig client
regard local time zone oversea jurisdict capit market equiti research post proprietari websit
ensur elig client receiv coverag initi chang rate target opinion time manner addit
distribut may done sale personnel via email fax electron mean regular mail client may also
receiv research via third parti vendor capit market also provid elig client access sparc firm
proprietari insight websit via email via third-parti vendor sparc contain market color commentari regard
subject compani firm current provid equiti research coverag research analyst may time time
includ short-term trade idea research report sparc short-term trade idea offer short-term view
secur may trade base market trade event result trade opportun may avail
short-term trade idea may differ price target recommend publish research report reflect
research analyst view long-term one year prospect subject compani result differ time horizon
methodolog and/or factor thu possibl subject compani common equiti consid long-term
sector perform even under-perform might present short-term buy opportun result temporari sell pressur
market convers subject compani common equiti rate long-term outperform could consid suscept
short-term downward price correct short-term trade idea rate part rate system
firm gener intend undertak oblig maintain updat short-term trade idea short-term trade
idea may suitabl investor tailor individu investor circumst object
investor make independ decis regard secur strategi discuss herein pleas contact
invest advisor institut salesperson inform regard capit market research
list recommend compani dissemin prior period pleas click
month histori sparc view http //www rbcinsightresearch com
view express report accur reflect person view respons analyst
subject secur issuer part compens respons analyst name herein directli
indirectli relat specif recommend view express respons analyst report
global industri classif standard gic develop exclus properti servic mark inc standard poor financi servic
llc licens use neither parti involv make compil gic gic classif make express impli
warranti represent respect standard classif result obtain use thereof parti herebi expressli disclaim warranti
origin accuraci complet merchant fit particular purpos respect standard classif without limit forego
event shall affili third parti involv make compil gic gic classif liabil direct indirect special
punit consequenti damag includ lost profit even notifi possibl damag
refer herein libor libo rate libor abbrevi mean london interbank offer rate administ benchmark administr
person take administr rate
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict capit
market may restrict publish research report time time due regulatori restrict and/ intern complianc polici case
latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject compani
capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri busi
secur broker dealer jurisdict full extent permit law neither capit market affili person accept
liabil whatsoev direct indirect consequenti loss aris connect use report inform contain herein
matter contain document may reproduc copi mean without prior written consent capit market instanc
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
